Implicit Bioscience
11 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Anti-CD14 Treatment With IC14 in Hospitalized ARDS Patients (NCT06513949) | Implicit Bioscience | 2026-06-17 |
| Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMI (NCT06678074) | Implicit Bioscience | 2025-02-06 |
| IC14 for Treatment of Acute Decompensated Heart Failure (NCT06556810) | Implicit Bioscience | 2024-10-17 |
| IC14 (Atibuclimab) in Arrhythmogenic Cardiomyopathy (NCT06275893) | Implicit Bioscience | 2024-03-29 |
| IC14 for Rapidly Progressive Amyotrophic Lateral Sclerosis (ALS) (NCT03474263) | Implicit Bioscience | 2019-09-01 |
| A Phase 2 Study of IC14 in Acute Respiratory Distress Syndrome (NCT03017547) | Implicit Bioscience | 2019-06-01 |
| IC14 in Adult Patients With Dengue Fever (NCT03875560) | Implicit Bioscience | 2019-05-01 |
| Dose-Escalation, Safety and Pharmacokinetic Study of IC14 in Motor Neurone Disease (NCT03487263) | Implicit Bioscience | 2017-10-01 |
Track Implicit Bioscience automatically
Every clearance here is in the API, with alerts when new ones post.